Merck snaps up cancer drug from China’s Kelun in $1.4bn deal

Merck snaps up cancer drug from China’s Kelun in $1.4bn deal

Source: 
Pharmaforum
snippet: 

Merck & Co has quietly added another drug to its immuno-oncology pipeline via an agreement with China’s Sichuan Kelun Pharmaceutical, and is keeping the details close to its chest.